Cite
HARVARD Citation
Esteyrie, V. et al. (2019). The GIRAFE phase II trial on MVCT-based "volumes of the day" and "dose of the day" addresses when and how to implement adaptive radiotherapy for locally advanced head and neck cancer. Clinical and translational radiation oncology. pp. 34-39. [Online].